Cargando…
The Safety of Chemotherapy for Breast Cancer Patients with Hepatitis C Virus Infection
Background: Hepatitis C virus (HCV) infection is one of the major causes of chronic liver disease, and more than 880,000 people are estimated to be infected with HCV in Japan. Little information is available on the outcomes of HCV during chemotherapy for solid tumors, and the impact of HCV infection...
Autores principales: | Miura, Yuji, Theriault, Richard L, Naito, Yoichi, Suyama, Koichi, Shimomura, Akihiko, Iwatani, Tsuguo, Miura, Daishu, Kawabata, Hidetaka, Kumada, Hiromitsu, Takano, Toshimi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726714/ https://www.ncbi.nlm.nih.gov/pubmed/23901352 http://dx.doi.org/10.7150/jca.6231 |
Ejemplares similares
-
Radiation-Induced Esophagitis Exacerbated by Everolimus
por: Miura, Yuji, et al.
Publicado: (2013) -
Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial
por: Takano, Toshimi, et al.
Publicado: (2021) -
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
por: Ozaki, Yukinori, et al.
Publicado: (2018) -
Ewing sarcoma of the liver with multilocular cystic mass formation: a case report
por: Ozaki, Yukinori, et al.
Publicado: (2015) -
Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype
por: Miura, Yuji, et al.
Publicado: (2014)